Navigation Links
NeuroCog Trials Appoints Industry Executive Michael Hufford, Ph.D. to Chief Operating Officer
Date:11/4/2011

Dr. Hufford received his B.A. with Distinction in psychology from Purdue University, and his M.S. and Ph.D. in clinical psychology from the University of Pittsburgh.  Subsequently, he was a Clinical and Research Fellow in Department of Psychiatry at Harvard Medical School at the McLean Hospital.  Dr. Hufford has more than 90 scientific publications and presentations, with multiple issued and pending patents.

About NeuroCog Trials

NeuroCog Trials Inc. is the leading cognition services company for the pharmaceutical industry.  For more than 10 years, NeuroCog Trials has provided consulting, site screening, rater training and certification, and data review services to more than 50 clinical trials in over 25 countries.  NeuroCog Trials has certified more than 4,000 neurocognitive testers and assured data quality for over 50,000 assessments across a variety of therapeutic areas, including schizophrenia, Alzheimer's disease, major depressive disorder, bipolar disorder and brain cancer.  Our mission is to facilitate the development of novel therapies to enhance cognition.  We bring to all of our work deep expertise, strategic innovation, and an unwavering commitment to research excellence.

For more information on NeuroCog Trials, its services, and licensing inquiries for its exclusive neuropsychological and functional capacity assessment batteries, please see www.neurocogtrials.com

CONTACT
Richard Keefe, Ph.D.
Founder & CEO
NeuroCog Trials
(919) 401-4642


'/>"/>
SOURCE NeuroCog Trials, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Data From REMEDEE Trial Featuring OrbusNeichs Combo™ Dual Therapy Stent to be Presented in Late Breaking Clinical Trials and First Report Investigations Session at TCT 2011
2. CTRI Confirms Leading Indian CRO Supports Majority of Hemophilia Trials in India
3. QIAGEN to Develop New Companion Diagnostic for Compound in Clinical Trials for Blood Cancers
4. Kibow Biotech, Inc. Secures $2.4 Million Towards Its Human Clinical Trials by Continued Veterinary Licensing Agreement
5. Middle East to be the Future in Clincial Trials
6. Glenmark Initiates Phase IIb Human Trials Globally for its Novel Molecule Revamilast
7. Start of in-Patient Clinical Trials With NT-KO-003, the First Neuroprotective Drug for Multiple Sclerosis Without Immunosuppressive Effects
8. Family Foundation of Business Leader Invests $4.55 Million in Northwest Biotherapeutics for Promising Clinical Trials in the US and Europe
9. Drug Dropout in Clinical Trials Is at Unsustainable Levels, According to Thomson Reuters, CMR International
10. ERA-EDTA Congress 2011: Late Breaking Clinical Trials I
11. ACT Announces First Patients Enrolled in Two Clinical Trials Using Embryonic Stem Cells to Treat Stargardts Disease and Dry Age-Related Macular Degeneration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 20, 2013 Oven Industries Inc. announces ... capabilities. The 5R6-900 benchtop controller has many outstanding user-friendly ... be plugged into the wall as a self-contained temperature ... distinctive detail makes the device unique, as well as ... temperature controller can also be used universally, which allows ...
(Date:5/20/2013)... Ga. , May 20, 2013  MiMedx Group, ... manufacturer and marketer of patent protected regenerative biomaterials and ... it has secured a revolving line of credit with ... which is secured by the Company,s accounts receivable and ... through May 1, 2014.  The facility will be used ...
(Date:5/20/2013)... 2013 Today, at the American Psychiatric Association ... James McGough , M.D., M.S., principal ... Institute for Neuroscience and Human Behavior and ... University of California Los Angeles (UCLA), and director of ... and ADHD at UCLA, presented the results of a ...
(Date:5/20/2013)... 2013  (PSHR) Pacific Shore Holdings, Inc. a ... a broad range of product categories lines, today ... firm, BlueWater Advisory Group, to provide strategic counsel ... and to direct the company,s outreach and investor ... Matthew Mills , Pacific Shore Holdings, ...
Breaking Biology Technology:New Laboratory Temperature Controller by Oven Industries 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5Pacific Shore Holdings Retains Investor Relations Firm 2
... Molecular Devices Limited, U.K., , ... The FlexStation scanning ... it ideal for kinetic, cell-based fluorometric assays, such as the ... Calcium (Ca 2+ ) is the most common signal transduction ...
... FOR DIVERSIFIED TARGETS, , , , , ... CELL TYPES , , HIGHER SIGNAL INTENSITY , ... COMPATIBLE WITH MORE TARGETS , , ... Calcium mobilization assays for screening GPCR targets are preferred techniques ...
... McGown, Ph.D. and Michael Su, M.S., ... Molecular Devices Corporation, 8/00 , , INTRODUCTION ... study eukaryotic gene expression. Dual geneticreporters are commonly used in ... differences in cell number, viabilityor transfection efficiency. One vector containing ...
Cached Biology Technology:Monitoring Receptor-Mediated Changes in [Ca2+]i Using Single-Wavelength and Dual-Wavelength Indicators on the FlexStation Workstation 2Monitoring Receptor-Mediated Changes in [Ca2+]i Using Single-Wavelength and Dual-Wavelength Indicators on the FlexStation Workstation 3Monitoring Receptor-Mediated Changes in [Ca2+]i Using Single-Wavelength and Dual-Wavelength Indicators on the FlexStation Workstation 4Monitoring Receptor-Mediated Changes in [Ca2+]i Using Single-Wavelength and Dual-Wavelength Indicators on the FlexStation Workstation 5Monitoring Receptor-Mediated Changes in [Ca2+]i Using Single-Wavelength and Dual-Wavelength Indicators on the FlexStation Workstation 6Monitoring Receptor-Mediated Changes in [Ca2+]i Using Single-Wavelength and Dual-Wavelength Indicators on the FlexStation Workstation 7Monitoring Receptor-Mediated Changes in [Ca2+]i Using Single-Wavelength and Dual-Wavelength Indicators on the FlexStation Workstation 8Monitoring Receptor-Mediated Changes in [Ca2+]i Using Single-Wavelength and Dual-Wavelength Indicators on the FlexStation Workstation 9FLIPR Calcium 3 Assay Kit Datasheet 2FLIPR Calcium 3 Assay Kit Datasheet 3Dual-Luciferase Quantitation in the LMax Microplate Luminometer (MaxLine Application Note #39) 2Dual-Luciferase Quantitation in the LMax Microplate Luminometer (MaxLine Application Note #39) 3Dual-Luciferase Quantitation in the LMax Microplate Luminometer (MaxLine Application Note #39) 4Dual-Luciferase Quantitation in the LMax Microplate Luminometer (MaxLine Application Note #39) 5Dual-Luciferase Quantitation in the LMax Microplate Luminometer (MaxLine Application Note #39) 6
(Date:5/20/2013)... Bristol and published online today in the Journal ... brain and inner ear developed in dinosaurs. , ... with Tom Hbner from the Niederschsische Landesmuseum in Hannover, ... dinosaurs. , The two palaeontologists studied different fossils of ... young (juvenile) individual of approximately three years of ...
(Date:5/19/2013)... and women of European descent inherit common foot disorders, ... including hammer or claw toe. Findings from the Framingham ... disorders in humansappear in Arthritis Care & Research ... the American College of Rheumatology (ACR). , Previous ... adults have foot disorders which may limit mobility and ...
(Date:5/19/2013)... Davis have engineered a strain of photosynthetic cyanobacteria to ... their findings today at the 113th General Meeting of ... we used synthetic biology approaches to probe and rewire ... for growth) cyanobacterial metabolism for the ability to grow ... on the study. He is part of Shota ...
Breaking Biology News(10 mins):Fossil brain teaser 2Blame your parents for bunion woes 2
... People who eat baked or broiled fish on a ... reducing their risk of developing mild cognitive impairment (MCI) ... at the annual meeting of the Radiological Society of ... to establish a direct relationship between fish consumption, brain ...
... It feels like bone. For the most part, it acts ... State University researchers have used a 3D printer to create ... orthopedic procedures, dental work, and to deliver medicine for treating ... for new bone to grow on and ultimately dissolves with ...
... residential soils study, one of few such U.S. studies ever ... from a study of residential soils in the city of ... U.S. urban soil studies ever conducted. The authors of ... journal Environmental Pollution , collected soils in the residential ...
Cached Biology News:Eating fish reduces risk of Alzheimer's disease 2UI engineers conduct residential soils study, one of few such US studies ever done 2UI engineers conduct residential soils study, one of few such US studies ever done 3
SDS-OutT SDS Precipitation Reagent...
... Disposable, clear, APET plastic tray. Ideal ... identify those trays used for multipurposes. Pour ... liquid. A marker or label may be ... stacking trays on rockers or shakers for ...
... disposable microfiltration devices for the fast and reliable ... l to 500 l. They can be used ... tubes. Product Features: High-flux Polyethersulphonemembrane ... hold up volume ( Fast and reproducible performance ...
... is a novel disposable spin filtration device ... bacterial lysates in plasmid purification procedures. ... disposable spin filtration device especially designed to ... plasmid purification procedures. The neutralized lysate is ...
Biology Products: